Global Biopharma Plastic Market Size Study, by Product Type, by Manufacturing Process, by Application, and Regional Forecasts 2022-2032

Description

The Global Biopharma Plastic Market was valued at approximately USD 17.52 billion in 2023 and is expected to expand at a CAGR of 5.70% over the forecast period 2024-2032. The increasing demand for biopharmaceutical production, advancements in single-use technologies, and the shift toward high-performance plastics are key factors driving market growth. Biopharma plastics have become essential components in bioprocessing, cell culture, and drug manufacturing, offering improved sterility, reduced contamination risks, and enhanced production efficiency.

The industry's shift toward disposable bioprocessing solutions has fueled the adoption of single-use bioreactors, containers, and pipings, particularly in monoclonal antibody and vaccine production. The rise of personalized medicine, regenerative therapies, and biosimilars has further amplified the need for high-quality, durable, and chemically resistant plastics. However, challenges such as regulatory constraints, material compatibility concerns, and the environmental impact of single-use plastics pose hurdles to market expansion. Nonetheless, ongoing R&D efforts in recyclable and biodegradable biopharma plastics are expected to mitigate environmental concerns and drive sustainable growth.

Geographically, North America dominates the biopharma plastic market, with the United States leading due to its robust pharmaceutical infrastructure, increasing investments in biologics, and growing adoption of advanced bioprocessing techniques. Meanwhile, Europe holds a significant share, supported by stringent regulatory frameworks, expanding biopharma manufacturing hubs, and increased focus on sustainability in drug production.

The Asia-Pacific region is anticipated to witness the fastest growth over the forecast period, propelled by rising biopharma investments in China, India, Japan, and South Korea. The region's booming contract manufacturing sector, increasing government initiatives for biopharma development, and growing demand for biosimilars are key factors stimulating market expansion. Additionally, Latin America and the Middle East & Africa are emerging markets, benefiting from expanding pharmaceutical capabilities, growing biologics production, and increasing foreign investments.

Major Market Players Included in This Report:

Thermo Fisher Scientific Inc.
Corning Incorporated
Sartorius AG
Danaher Corporation
Eppendorf AG
Saint-Gobain Life Sciences
Merck KGaA
Lonza Group AG
W.L. Gore & Associates Inc.
Avantor, Inc.
Pall Corporation
Celanese Corporation
Mitsubishi Chemical Holdings Corporation
Cargill, Incorporated
Sumitomo Bakelite Co., Ltd.

The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Product Type:

Single-Use Bioreactors and Fermenters
Multi-Use Bioreactors and Fermenters
Bioprocess Containers
Piping and Fittings
Accessories

By Manufacturing Process:

Injection Molding
Blow Molding
Extrusion
Thermoforming
Other (e.g., Additive Manufacturing)

By Application:

Cell Culture
Monoclonal Antibody Production
Vaccine Production
Stem Cell Culture
Gene Therapy

By End User:

Biopharmaceutical Companies
Research Institutes
Contract Manufacturing Organizations (CMOs)

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
Rest of Europe

Asia Pacific:

China
India
Japan
Australia
South Korea
Rest of Asia Pacific

Latin America:

Brazil
Mexico
Rest of Latin America

Middle East & Africa:

Saudi Arabia
South Africa
Rest of Middle East & Africa

Years Considered for the Study:

Historical Year: 2022
Base Year: 2023
Forecast Period: 2024 to 2032

Key Takeaways:

Market estimates and forecasts for 10 years (2022-2032).
Annualized revenue breakdown and regional-level analysis for each market segment.
Detailed geographical assessment with country-level insights.
Competitive landscape overview with company profiles and key market strategies.
Analysis of key business trends and recommendations for market players.
Evaluation of market structure and competition in the biopharma plastic sector.
Demand-side and supply-side dynamics analysis.

Chapter 1. Global Biopharma Plastic Market Executive Summary

1.1. Global Biopharma Plastic Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. {By Product Type}
- 1.3.2. {By Manufacturing Process}
- 1.3.3. {By Application}
- 1.3.4. {By End User}
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biopharma Plastic Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Biopharma Plastic Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Demand for Single-Use and Multi-Use Bioreactors
- 3.1.2. Technological Advancements in Bioprocess Plastics
- 3.1.3. Growing Emphasis on Sustainability and Regulatory Support
3.2. Market Challenges
- 3.2.1. Regulatory Constraints and Material Compatibility Issues
- 3.2.2. Environmental Impact and Waste Management Concerns
3.3. Market Opportunities
- 3.3.1. Expansion of Biopharmaceutical Production and Biosimilar Demand
- 3.3.2. Innovation in Recyclable and Biodegradable Plastics
- 3.3.3. Strategic Collaborations and Increased R&D Investments

Chapter 4. Global Biopharma Plastic Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biopharma Plastic Market Size & Forecasts by Product Type 2022-2032

5.1. Segment Dashboard
5.2. Global Biopharma Plastic Market: {Product Type} Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Single-Use Bioreactors and Fermenters
- 5.2.2. Multi-Use Bioreactors and Fermenters
- 5.2.3. Bioprocess Containers
- 5.2.4. Piping and Fittings
- 5.2.5. Accessories

Chapter 6. Global Biopharma Plastic Market Size & Forecasts by Manufacturing Process 2022-2032

6.1. Segment Dashboard
6.2. Global Biopharma Plastic Market: {Manufacturing Process} Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Injection Molding
- 6.2.2. Blow Molding
- 6.2.3. Extrusion
- 6.2.4. Thermoforming
- 6.2.5. Other (e.g., Additive Manufacturing)

Chapter 7. Global Biopharma Plastic Market Size & Forecasts by Application 2022-2032

7.1. Segment Dashboard
7.2. Global Biopharma Plastic Market: {Application} Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Cell Culture
- 7.2.2. Monoclonal Antibody Production
- 7.2.3. Vaccine Production
- 7.2.4. Stem Cell Culture
- 7.2.5. Gene Therapy

Chapter 8. Global Biopharma Plastic Market Size & Forecasts by End User and Region 2022-2032

8.1. By End User
- 8.1.1. Biopharmaceutical Companies
- 8.1.2. Research Institutes
- 8.1.3. Contract Manufacturing Organizations (CMOs)
8.2. By Region
- 8.2.1. North America Biopharma Plastic Market
  - 8.2.1.1. U.S. Biopharma Plastic Market
  - 8.2.1.2. Canada Biopharma Plastic Market
- 8.2.2. Europe Biopharma Plastic Market
  - 8.2.2.1. UK Biopharma Plastic Market
  - 8.2.2.2. Germany Biopharma Plastic Market
  - 8.2.2.3. France Biopharma Plastic Market
  - 8.2.2.4. Spain Biopharma Plastic Market
  - 8.2.2.5. Italy Biopharma Plastic Market
  - 8.2.2.6. Rest of Europe Biopharma Plastic Market
- 8.2.3. Asia Pacific Biopharma Plastic Market
  - 8.2.3.1. China Biopharma Plastic Market
  - 8.2.3.2. India Biopharma Plastic Market
  - 8.2.3.3. Japan Biopharma Plastic Market
  - 8.2.3.4. Australia Biopharma Plastic Market
  - 8.2.3.5. South Korea Biopharma Plastic Market
  - 8.2.3.6. Rest of Asia Pacific Biopharma Plastic Market
- 8.2.4. Latin America Biopharma Plastic Market
  - 8.2.4.1. Brazil Biopharma Plastic Market
  - 8.2.4.2. Mexico Biopharma Plastic Market
  - 8.2.4.3. Rest of Latin America Biopharma Plastic Market
- 8.2.5. Middle East & Africa Biopharma Plastic Market
  - 8.2.5.1. Saudi Arabia Biopharma Plastic Market
  - 8.2.5.2. South Africa Biopharma Plastic Market
  - 8.2.5.3. Rest of Middle East & Africa Biopharma Plastic Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Thermo Fisher Scientific Inc.
- 9.1.2. Corning Incorporated
- 9.1.3. Sartorius AG
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Thermo Fisher Scientific Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Danaher Corporation
- 9.3.3. Eppendorf AG
- 9.3.4. Saint-Gobain Life Sciences
- 9.3.5. Merck KGaA
- 9.3.6. Lonza Group AG
- 9.3.7. W.L. Gore & Associates Inc.
- 9.3.8. Avantor, Inc.
- 9.3.9. Pall Corporation
- 9.3.10. Celanese Corporation
- 9.3.11. Mitsubishi Chemical Holdings Corporation
- 9.3.12. Cargill, Incorporated
- 9.3.13. Sumitomo Bakelite Co., Ltd.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes